Form 4 for ORMP ORAMED PHARMACEUTICALS INC.
Accepted 2023-03-15 00:00:00 ET · period of report 2023-03-14 · accession 0001209191-23-018956 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-03-15 | 2023-03-14 | ORMP | KIDRON NADAV | Pres, CEO, Dir | P - Purchase | $2.01 | +100.0K | 100.0K | New | +$201.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-14 | P | A | 100,000 | $2.01 | 100,000 | I By wholly-owned corporation | — | — |